Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

130.32
Delayed Data
As of Apr 28
 -0.60 / -0.46%
Today’s Change
92.03
Today|||52-Week Range
132.95
+15.65%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close130.92
Today’s open131.26
Day’s range129.80 - 131.68
Volume221,717
Average volume (3 months)357,778
Market cap$5.7B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.53%
Earnings growth (next 5 years)+31.00%
Revenue growth (last year)+43.09%
P/E ratio121.8
Price/Sales12.92
Price/Book15.05

Competitors

 Today’s
change
Today’s
% change
MASIMasimo Corp+0.88+0.86%
DXCMDexCom Inc+0.03+0.04%
WSTWest Pharmaceutical ...-0.66-0.71%
NUVANuVasive Inc-0.30-0.41%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts